 | | PRD_000909 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-L-leucinamide | | Formula: | C25 H42 B N3 O6 | | Definition date: | 2013-06-26 | | Last modified: | 2013-06-26 |
|
 | | PRD_001126 | | Name: | Microcin C7 ANALOG | | Formula: | C28 H51 N12 O11 Se | | Definition date: | 2013-06-26 | | Last modified: | 2013-06-26 |
|
 | | PRD_001122 | | Name: | CYCLOSPORIN D | | Formula: | C64 H115 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN D IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN IN RESIDUE 6 (ABA6VAL). THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 7 TO BE N-METHYL-L-ALANINE. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_001123 | | Name: | CYCLOSPORIN C | | Formula: | C64 H114 N10 O14 | | Description: | CYCLOSPORIN C IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. CYCLOSPORIN C IS A NATURAL ANALOG OF CYCLOSPORIN A, OBTAINED FROM A DIFFERENT NUTRIENT BROTH AND DIFFERS FROM CYCLOSPORIN A IN RESIDUE 6 (ABA6THR). THIS IS A CYCLOSPORIN C VARIANT THAT DIFFERS AT 1, 3, AND 9 POSITIONS. | | Definition date: | 2013-06-20 | | Last modified: | 2013-06-20 |
|
 | | PRD_001102 | | Name: | M48U12 | | Formula: | C133 H217 N39 O31 S6 | | Definition date: | 2013-06-19 | | Last modified: | 2013-06-19 |
|
 | | PRD_001108 | | Name: | CYCLOSPORIN A | | Formula: | C63 H113 N11 O12 | | Description: | CYCLOSPORIN IS A CYCLIC UNDECAPEPTIDE. CYCLIZATION IS ACHIEVED BY LINKING THE N- AND THE C- TERMINI. THE CYCLOSPORIN MOLECULE WAS MODIFIED AT POSITION 8 TO BE 4,N-DIMETHYLNORLEUCINE. | | Definition date: | 2013-06-19 | | Last modified: | 2013-06-19 |
|
 | | PRD_000925 | | Name: | Caspase inhibitor | | Formula: | C42 H58 N6 O12 | | Definition date: | 2013-06-12 | | Last modified: | 2013-06-12 |
|
 | | PRD_001094 | | Name: | CD4-MIMETIC MINIPROTEIN M48U1 | | Formula: | C133 H216 N38 O32 S6 | | Definition date: | 2013-06-12 | | Last modified: | 2013-06-12 |
|
 | | PRD_001099 | | Name: | CD4-MIMETIC MINIPROTEIN M48U7 | | Formula: | C131 H214 N38 O33 S6 | | Definition date: | 2013-06-12 | | Last modified: | 2013-06-12 |
|
 | | PRD_000995 | | Name: | D-peptide inhibitor DPMI-delta | | Formula: | C73 H106 F3 N18 O18 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-10 |
|
 | | PRD_000967 | | Name: | macrocyclic peptidomimetic | | Formula: | C56 H84 N16 O9 | | Definition date: | 2013-03-06 | | Last modified: | 2013-06-07 |
|
 | | PRD_000893 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-15-(3-[METHYL(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-8-(2-METHYLPROPYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C54 H69 N7 O11 S | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000898 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S,16S,19S,22S)-16-(3-AMINO-3-OXOPROPYL)-2,13-DIBENZYL-12,22-DIHYDROXY-3,5,17-TRIMETHYL-8-(2-METHYLPROPYL)-4,7,10,15,18,21-HEXAOXO-19-(PROPAN-2-YL)-3,6,9,14,17,20-HEXAAZATRICOSAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE (NON-PREFERRED NAME) | | Formula: | C50 H74 N8 O12 | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000899 | | Name: | METHYL (2S)-1-[(2R,5S,8S,12S,13S)-2,13-DIBENZYL-12-HYDROXY-3,5-DIMETHYL-8-(2-METHYLPROPYL)-15-(3-[(METHYLSULFONYL)AMINO]-5-{[(1R)-1-PHENYLETHYL]CARBAMOYL}PHENYL)-4,7,10,15-TETRAOXO-3,6,9,14-TETRAAZAPENTADECAN-1-OYL]PYRROLIDINE-2-CARBOXYLATE | | Formula: | C53 H67 N7 O11 S | | Definition date: | 2013-01-16 | | Last modified: | 2013-06-03 |
|
 | | PRD_000910 | | Name: | B4Z inhibitor | | Formula: | C24 H44 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000911 | | Name: | C4Z inhibitor | | Formula: | C27 H42 N6 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000912 | | Name: | C6Z inhibitor | | Formula: | C34 H54 N8 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000921 | | Name: | Noxa BH3 peptide (cysteine-mediated cross-linked) | | Formula: | C106 H179 N33 O25 S2 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000922 | | Name: | PL-42 | | Formula: | C39 H63 N9 O14 P S | | Definition date: | 2013-04-03 | | Last modified: | 2013-06-03 |
|
 | | PRD_000924 | | Name: | Ac-DEVD-CMK | | Formula: | C21 H33 Cl N4 O11 | | Definition date: | 2013-05-08 | | Last modified: | 2013-06-03 |
|
 | | PRD_000937 | | Name: | peptide inhibitor | | Formula: | C33 H50 N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000940 | | Name: | D-PHE-PRO-D-ARG-D-THR DERIVED DIRECT THROMBIN INHIBITOR | | Formula: | C24 H39 N8 O5 | | Definition date: | 2013-04-17 | | Last modified: | 2013-06-03 |
|
 | | PRD_000941 | | Name: | [Aba5,14]BTD-2 | | Formula: | C80 H150 N36 O18 S4 | | Definition date: | 2013-02-27 | | Last modified: | 2013-06-03 |
|
 | | PRD_000184 | | Name: | Microcin J25 | | Formula: | C101 H140 N23 O27 | | Definition date: | 2012-12-12 | | Last modified: | 2013-06-03 |
|
 | | PRD_000960 | | Name: | N-[(benzyloxy)carbonyl]-L-valyl-L-alpha-glutamyl-N-[(2R)-1-carboxy-3-oxo-4-(2,3,5,6-tetrafluorophenoxy)butan-2-yl]-L-isoleucinamide | | Formula: | C35 H42 F4 N4 O11 | | Definition date: | 2013-03-20 | | Last modified: | 2013-06-03 |
|
